Mangoceuticals (MGRX) EPS (Weighted Average and Diluted) Growth (1y) (2024 - 2026)
Mangoceuticals (MGRX) EPS (Weighted Average and Diluted) Growth (1y) (2024 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 14.60% |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 1,240.00% |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 34.43% |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | -68.70% |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 64.29% |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | -67.74% |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 37.50% |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | -33.33% |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 266.67% |
| 10 | Mangoceuticals | 5.25 Mn | 5.06 Mn | 29,001.00 | 80.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 80.36% |
| Dec 31, 2025 | 98.08% |
| Sep 30, 2025 | 39.47% |
| Jun 30, 2025 | 58.39% |
| Mar 31, 2025 | 25.33% |
| Dec 31, 2024 | 72.63% |
| Sep 30, 2024 | 32.94% |
| Jun 30, 2024 | -878.57% |
| Mar 31, 2024 | -559.45% |